Yoshida Kazuya, Yamaguchi Shinya, Kawaguchi Akio
Dept. of Surgery, Inoue Hospital.
Gan To Kagaku Ryoho. 2007 Apr;34(4):601-4.
The patient was a 50-year-old male with advanced gastric cancer. Laparoscopy showed peritoneal metastases. We thought a complete resection would be difficult, so he was given neoadjuvant chemotherapy combined with paclitaxel (200 mg, day 1, 15) and TS-1 (120 mg/day, for days 1-14 with a 2-week rest). After 3 courses of this neoadjuvant chemotherapy, the tumor decreased in size. Laparoscopy showed no peritoneal metastasis, and thus a total gastrectomy with splenectomy and D 2 lymph node dissection was performed. The pathological diagnosis was sig, LM, type 4, pT 3 (SE), sci, INFgamma, ly 0, v 0, pN 0, pPM (-), pDM (-), and the antitumor efficacy of this therapy was Grade 0 histologically. Combined chemotherapy of biweekly paclitaxel and TS-1 was thought to be an effective neoadjuvant chemotherapy for advanced gastric cancer in this case.
该患者为一名50岁的晚期胃癌男性。腹腔镜检查显示有腹膜转移。我们认为完整切除困难,因此给予他新辅助化疗,联合使用紫杉醇(第1、15天,200毫克)和替吉奥(120毫克/天,第1 - 14天,休息2周)。经过3个疗程的新辅助化疗后,肿瘤体积缩小。腹腔镜检查显示无腹膜转移,于是进行了全胃切除术、脾切除术及D2淋巴结清扫术。病理诊断为黏液腺癌,低分化,4型,pT3(SE),浆膜侵犯,INFγ,ly0,v0,pN0,pPM(-),pDM(-),该治疗的抗肿瘤疗效在组织学上为0级。在本病例中,每两周一次的紫杉醇和替吉奥联合化疗被认为是晚期胃癌有效的新辅助化疗。